However, as other tumors such as chromophobe renal cell carcinoma, basal cell carcinoma, and mesothelioma have been reported to be reactive to GATA3 [24], it is advisable to use more than one marker to confirm the mammary origin of a metastatic carcinoma. This evidence concerns the gene GATA3 and basal cell carcinoma.